These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 16494636)
1. Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better? Watson T; Lip GY Int J Clin Pract; 2006 Mar; 60(3):252-5. PubMed ID: 16494636 [No Abstract] [Full Text] [Related]
2. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
3. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation. Morrison CM; Gainsborough N; Rajkumar C Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089 [No Abstract] [Full Text] [Related]
4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
5. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564 [TBL] [Abstract][Full Text] [Related]
6. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. Francescone S; Halperin JL J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567 [No Abstract] [Full Text] [Related]
7. Aspirin for atrial fibrillation. Douglas M; Strelnick A J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329 [No Abstract] [Full Text] [Related]
8. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
9. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
10. Balancing risk in atrial fibrillation. Ali SN; Hardman SM Practitioner; 2001 May; 245(1622):357. PubMed ID: 11373966 [No Abstract] [Full Text] [Related]
11. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
12. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
14. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
15. Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation. Weintraub WS J Am Coll Cardiol; 2008 Feb; 51(8):816-7. PubMed ID: 18294565 [No Abstract] [Full Text] [Related]
16. [Risks in atrial fibrillation and simultaneous renal failure]. Habich S Dtsch Med Wochenschr; 2012 Sep; 137(38):1840. PubMed ID: 23133847 [No Abstract] [Full Text] [Related]
18. Atrial fibrillation and thromboembolic risk: what is the extent of adherence to guidelines in clinical practice? Dores H; Cardiga R; Ferreira R; Araújo I; Gândara F; Abreu A; Marques F; Leitão A; Fonseca C; Ceia F Rev Port Cardiol; 2011 Feb; 30(2):171-80. PubMed ID: 21553610 [TBL] [Abstract][Full Text] [Related]
19. The need for new oral anticoagulants in clinical practice. Hylek EM J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764 [TBL] [Abstract][Full Text] [Related]
20. Why are we ignoring guideline recommendations? Alpert JS Am J Med; 2010 Feb; 123(2):97-8. PubMed ID: 20103012 [No Abstract] [Full Text] [Related] [Next] [New Search]